Imperative Care, Inc
$45.6M 5,115 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Daiichi Sankyo Inc.
Daiichi Sankyo Inc. reported $45,354,935.06 across General Payments, Research, and Ownership to 55,658 physicians and teaching hospitals across 66,466 transactions.
- $45.4M Top 10% payer
- All-tracks total
- 66,466 Top 10% volume
- Transactions
- 55,658 Top 10% reach
- Recipients
- +$2.5M
- General Payments vs PY2023
Daiichi Sankyo Inc. reported $45,354,935.06 across all CMS Open Payments tracks (General + Research + Ownership) to 55,658 physicians and teaching hospitals in Program Year 2024 - ranking #54 of 1,925 reporting manufacturers (0.3% of the all-tracks industry total); General Payments alone were $6,908,309.83, averaging $814.89 per recipient.
How Daiichi Sankyo Inc.'s $45.4M all-tracks total breaks down
Daiichi Sankyo Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
A
94/100
Total payments
A
100/100
Transaction volume
A
100/100
Physician reach
A
100/100
Payment type diversity
C
77/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer daiichi-sankyo-inc Daiichi Sankyo Inc.
$45.4M · #54/1,925 · 0.3% industry · PY2024
- TOT $45.4M
- RANK #54
- SHARE 0.3%
- TXN 66,466
- RCP 55,658
- CAT 6
- GEN $6.9M
- ΔGEN +$2.5M
- TOP1 18.8%
- PY 2024
Volume peers
Nearest volume peer: Imperative Care, Inc ($45.6M)
Daiichi Sankyo Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Daiichi Sankyo Inc.'s CMS-reported General Payments increased by $2.5M (+56.7%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: DAIICHI SANKYO INC.PY2023: DAIICHI SANKYO INC.PY2024: Daiichi Sankyo Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $4,409,265.05
- PY2024
- $6,908,309.83
What the Data Shows for Daiichi Sankyo Inc.
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Daiichi Sankyo Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
"Consulting Fee" leads the 6-category general-payment breakdown below at $2.3M (32.8% of General Payments, 1,211 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
"Consulting Fee" leads Daiichi Sankyo Inc.'s 6-category general-payment breakdown at $2.3M, 32.8% of the reported total.
Daiichi Sankyo Inc. reports 6 general-payment categories - the top three are Consulting Fee (32.8%), Grant (20.3%), and Compensation for Services Other Than Consulting (19.0%). The remaining 3 categories make up 27.9% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Daiichi Sankyo Inc. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $2.3M | 1,211 | 32.8% |
| Grant | $1.4M | 6 | 20.3% |
| Compensation for Services Other Than Consulting | $1.3M | 383 | 19.0% |
| Food and Beverage | $1.2M | 52,285 | 18.1% |
| Travel and Lodging | $459.2K | 1,076 | 6.6% |
| Education | $219.1K | 697 | 3.2% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $1,719,181.25 (24.9%) of $6,908,309.83 in this company's General Payments records across 19,638 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Daiichi Sankyo Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Dana-Farber Cancer Institute
$1,300,000.00 across 1 reported transactions
- 2
Jonathan Chung
$123,165.00 across 29 reported transactions
- 3
Janice Jean Phillips Dutcher
$107,656.25 across 9 reported transactions
- 4
Charles Powell
$99,187.50 across 11 reported transactions
- 5
Lisa Lancaster
$89,172.50 across 32 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Daiichi Sankyo Inc. ranks #54 of 1,925 by total payments (top 3% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,388 of 1,838 by HHI (bottom 25% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Astellas Pharma Global Development : $662.0K total payments, HHI 386
- Breg, Inc : $959.96 total payments, HHI 385
- Impulse Dynamics (USA) Inc. : $1.3M total payments, HHI 385
- Medela LLC : $63.1K total payments, HHI 384
- Ovesco Endoscopy USA, Inc. : $61.0K total payments, HHI 384
- Augmedics Inc. : $233.7K total payments, HHI 383
- Daiichi Sankyo Inc. (this company) : $6.9M total payments, HHI 382
- Biocomposites Inc : $138.8K total payments, HHI 381
- Dental Health Products, Inc. : $7.5K total payments, HHI 380
- XVIVO Perfusion Inc. : $51.8K total payments, HHI 377
- Carl Zeiss Meditec, Inc. : $938.6K total payments, HHI 376
- CDC Medical LLC : $22.6K total payments, HHI 376
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Daiichi Sankyo Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Daiichi Sankyo Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Daiichi Sankyo Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Scientia Vascular
$46.9M 191 recipients
Compare payment profiles
Cleerly, Inc.
$47.5M 910 recipients
Compare payment profiles
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$47.9M 137,083 recipients
Compare payment profiles
Sumitomo Pharma America, Inc.
$48.1M 94,811 recipients
Compare payment profiles
Sanofi Pasteur Inc.
$42.5M 14,446 recipients
Compare payment profiles
Put this to use
Daiichi Sankyo Inc. ranks #54 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See where Daiichi Sankyo Inc. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Daiichi Sankyo Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.